[DOI] [PMC free article] [PubMed] [Google Scholar] 45.Exenatide extended release in patients with type 1 diabetes with and without residual insulin production
Saraswat P, Singh S, Prasad M, Misra R, Rajput VD, Ranjan R
We found no effect for Genotype, Group or a Genotype*Group interaction ( 1c Right )
That creates a wider set of non-injectable entry points for self-pay patients, though patients should still ask detailed questions about formulation type, expected efficacy, fulfillment pathway, and whether they are receiving a brand-name or compounded product
While both peptides may complement wellness goals, sermorelin is often chosen for hormone optimization and body composition support, whereas BPC-157 is more commonly used for recovery and healing